These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 38626183)
1. The association between HIV pretreatment drug resistance and virological outcomes in children and adults in sub-Saharan Africa: A systematic review and meta-analysis. Takem EN; Coox C; Shang J; Ndongmo C; Dokubo EK PLoS One; 2024; 19(4):e0300456. PubMed ID: 38626183 [TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
3. High levels of pre-treatment HIV drug resistance and treatment failure in Nigerian children. Boerma RS; Boender TS; Sigaloff KC; Rinke de Wit TF; van Hensbroek MB; Ndembi N; Adeyemo T; Temiye EO; Osibogun A; Ondoa P; Calis JC; Akanmu AS J Int AIDS Soc; 2016; 19(1):21140. PubMed ID: 27836020 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the management of pretreatment HIV drug resistance by oligonucleotide ligation assay: a randomised controlled trial. Chung MH; McGrath CJ; Beck IA; Levine M; Milne RS; So I; Andersen N; Dross S; Coombs RW; Chohan B; Yatich N; Kiptinness C; Sakr SR; Kiarie JN; Frenkel LM Lancet HIV; 2020 Feb; 7(2):e104-e112. PubMed ID: 31818716 [TBL] [Abstract][Full Text] [Related]
5. Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study. Inzaule SC; Hamers RL; Noguera-Julian M; Casadellà M; Parera M; Kityo C; Steegen K; Naniche D; Clotet B; Rinke de Wit TF; Paredes R; Lancet HIV; 2018 Nov; 5(11):e638-e646. PubMed ID: 30282603 [TBL] [Abstract][Full Text] [Related]
6. Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa. Boender TS; Kityo CM; Boerma RS; Hamers RL; Ondoa P; Wellington M; Siwale M; Nankya I; Kaudha E; Akanmu AS; Botes ME; Steegen K; Calis JC; Rinke de Wit TF; Sigaloff KC J Antimicrob Chemother; 2016 Oct; 71(10):2918-27. PubMed ID: 27342546 [TBL] [Abstract][Full Text] [Related]
7. HIV-1 pretreatment drug resistance negatively impacts outcomes of first-line antiretroviral treatment. Hermans LE; Hofstra LM; Schuurman R; Ter Heine R; Burger DM; Talboom SAJ; De Jong D; Tempelman HA; Venter WDF; Nijhuis M; Wensing AMJ AIDS; 2022 Jun; 36(7):923-931. PubMed ID: 35113046 [TBL] [Abstract][Full Text] [Related]
8. HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study. Hamers RL; Wallis CL; Kityo C; Siwale M; Mandaliya K; Conradie F; Botes ME; Wellington M; Osibogun A; Sigaloff KC; Nankya I; Schuurman R; Wit FW; Stevens WS; van Vugt M; de Wit TF; Lancet Infect Dis; 2011 Oct; 11(10):750-9. PubMed ID: 21802367 [TBL] [Abstract][Full Text] [Related]
9. Clinical Impact of Pretreatment Human Immunodeficiency Virus Drug Resistance in People Initiating Nonnucleoside Reverse Transcriptase Inhibitor-Containing Antiretroviral Therapy: A Systematic Review and Meta-analysis. Bertagnolio S; Hermans L; Jordan MR; Avila-Rios S; Iwuji C; Derache A; Delaporte E; Wensing A; Aves T; Borhan ASM; Leenus A; Parkin N; Doherty M; Inzaule S; Mbuagbaw L J Infect Dis; 2021 Aug; 224(3):377-388. PubMed ID: 33202025 [TBL] [Abstract][Full Text] [Related]
10. Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa. Boender TS; Hoenderboom BM; Sigaloff KC; Hamers RL; Wellington M; Shamu T; Siwale M; Labib Maksimos EE; Nankya I; Kityo CM; Adeyemo TA; Akanmu AS; Mandaliya K; Botes ME; Ondoa P; Rinke de Wit TF Clin Infect Dis; 2015 Dec; 61(11):1749-58. PubMed ID: 26240203 [TBL] [Abstract][Full Text] [Related]
11. Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study. Hamers RL; Schuurman R; Sigaloff KC; Wallis CL; Kityo C; Siwale M; Mandaliya K; Ive P; Botes ME; Wellington M; Osibogun A; Wit FW; van Vugt M; Stevens WS; de Wit TF; Lancet Infect Dis; 2012 Apr; 12(4):307-17. PubMed ID: 22036233 [TBL] [Abstract][Full Text] [Related]
12. Impact of pretreatment low-abundance HIV-1 drug resistance on virological failure after 1 year of antiretroviral therapy in China. Li M; Song C; Hu J; Dong A; Kang R; Feng Y; Xing H; Ruan Y; Shao Y; Hong K; Liao L J Antimicrob Chemother; 2023 Nov; 78(11):2743-2751. PubMed ID: 37769159 [TBL] [Abstract][Full Text] [Related]
13. Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children - a EuroCoord-CHAIN-EPPICC joint project. Ngo-Giang-Huong N; Wittkop L; Judd A; Reiss P; Goetghebuer T; Duiculescu D; Noguera-Julian A; Marczynska M; Giacquinto C; Ene L; Ramos JT; Cellerai C; Klimkait T; Brichard B; Valerius N; Sabin C; Teira R; Obel N; Stephan C; de Wit S; Thorne C; Gibb D; Schwimmer C; Campbell MA; Pillay D; Lallemant M; BMC Infect Dis; 2016 Nov; 16(1):654. PubMed ID: 27825316 [TBL] [Abstract][Full Text] [Related]
14. Increasing Prevalence of HIV Pretreatment Drug Resistance in Women But Not Men in Rural Uganda During 2005-2013. McCluskey SM; Lee GQ; Kamelian K; Kembabazi A; Musinguzi N; Bwana MB; Muzoora C; Haberer JE; Hunt PW; Martin JN; Boum Y; Bangsberg DR; Harrigan PR; Siedner MJ AIDS Patient Care STDS; 2018 Jul; 32(7):257-264. PubMed ID: 29985647 [TBL] [Abstract][Full Text] [Related]
15. Pre-treatment HIV-1 drug resistance in antiretroviral therapy-naive adults in Eastern Africa: a systematic review and meta-analysis. Ntamatungiro AJ; Kagura J; Weisser M; Francis JM J Antimicrob Chemother; 2022 Nov; 77(12):3231-3241. PubMed ID: 36225089 [TBL] [Abstract][Full Text] [Related]
16. Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children. Kityo C; Boerma RS; Sigaloff KCE; Kaudha E; Calis JCJ; Musiime V; Balinda S; Nakanjako R; Boender TS; Mugyenyi PN; Rinke de Wit TF J Antimicrob Chemother; 2017 Sep; 72(9):2587-2595. PubMed ID: 28673027 [TBL] [Abstract][Full Text] [Related]
17. HIV-1 pretreatment drug resistance in vertically infected children is associated with poor virological response to protease inhibitor (PI)-based first-line antiretroviral therapy (ART): results from a cohort study in Argentina. Rozenszajn M; Arazi-Caillaud S; Taicz M; Bologna R; Mangano A; Aulicino PC J Antimicrob Chemother; 2022 Jun; 77(7):1969-1973. PubMed ID: 35512329 [TBL] [Abstract][Full Text] [Related]
18. The relative contributions of HIV drug resistance, nonadherence and low-level viremia to viremic episodes on antiretroviral therapy in sub-Saharan Africa. Inzaule SC; Bertagnolio S; Kityo CM; Siwale M; Akanmu S; Wellington M; de Jager M; Ive P; Mandaliya K; Stevens W; Boender TS; Ondoa P; Sigaloff KCE; Rinke de Wit TF; Hamers RL AIDS; 2020 Aug; 34(10):1559-1566. PubMed ID: 32675566 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Protease Inhibitor/Nucleos(t)ide Reverse Transcriptase Inhibitor-Based Second-line Antiretroviral Therapy for the Treatment of Human Immunodeficiency Virus Type 1 Infection in Sub-Saharan Africa: A Systematic Review and Meta-analysis. Stockdale AJ; Saunders MJ; Boyd MA; Bonnett LJ; Johnston V; Wandeler G; Schoffelen AF; Ciaffi L; Stafford K; Collier AC; Paton NI; Geretti AM Clin Infect Dis; 2018 Jun; 66(12):1846-1857. PubMed ID: 29272346 [TBL] [Abstract][Full Text] [Related]
20. HIV-1 Drug Resistance Detected by Next-Generation Sequencing among ART-Naïve Individuals: A Systematic Review and Meta-Analysis. Ouyang F; Yuan D; Zhai W; Liu S; Zhou Y; Yang H Viruses; 2024 Feb; 16(2):. PubMed ID: 38400015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]